Memorial Sloan-Kettering Clinical Genetics Service Chief Kenneth Offit discusses ways for women to clearly assess their risk for breast and ovarian cancer.

Memorial Sloan-Kettering researchers have developed innovative ways to study some skin diseases, including melanoma skin cancer.

Dr. Lima is one of 27 biomedical researchers in the country being named an HHMI investigator today. This elite group of scientists will receive approximately $150 million over the next five years.

For some patients with brain tumors involving regions of the brain related to speech or movement, surgery is performed while the patient is awake, which can improve the procedure’s safety and effectiveness.

An analysis of endometrial cancers reveals genetic information that should improve diagnosis and guide treatments for women with an aggressive form of the disease.

Physician-scientist Liang Deng cares for patients with melanoma and other skin cancers, and also conducts innovative research on poxviruses.

Two clinical trials of targeted therapies led by Memorial Sloan-Kettering investigators show promising results against different types of sarcoma.